SCHEMBL3980259

SCHEMBL3980259

NC(=O)N(S)c1cccc(OCCCOc2ccccc2-c2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.46
LMNA P02545 3/20 0.46
ALDH1A1 P00352 8/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
HTT P42858 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
MAPK1 P28482 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
TP53 P04637 1/20 0.43
RAB9A P51151 1/20 0.43
FFAR4 Q5NUL3 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
PKM P14618 1/20 0.41
HTR7 P34969 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3974854 0.98 KDM4E (0.49) KDM4ELMNAALDH1A1SMN1; SMN2HTT
SCHEMBL4267805 0.97 KDM4E (0.48) KDM4ELMNAALDH1A1SMN1; SMN2HTT
SCHEMBL4983235 0.89 KDM4E (0.41) KDM4ELMNAALDH1A1SMN1; SMN2FFAR4
SCHEMBL4982625 0.88 KDM4E (0.42) KDM4ELMNAALDH1A1SMN1; SMN2HTT
SCHEMBL4982648 0.88 FABP4 (0.41) KDM4ELMNAALDH1A1SMN1; SMN2FFAR4
SCHEMBL4980626 0.87 KDM4E (0.42) KDM4ELMNAALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL4980205 0.87 L3MBTL1 (0.43) KDM4ELMNAALDH1A1SMN1; SMN2HTT
SCHEMBL4979394 0.87 PTGER1 (0.40) KDM4ELMNAFFAR4HTR7
SCHEMBL3977090 0.87 PRSS1 (0.51) KDM4EALDH1A1SMN1; SMN2
SCHEMBL3975170 0.86 FFAR1 (0.49) FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2056810-A2 THIOUREA COMPOUNDS National Health Research Institutes (TW) 2009-05-13 EP disclosed
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed
WO-2008022204-A2 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096875-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, ETV6 KDM4E 1989/4885LMNA 4873/4885ALDH1A1 820/4885
US-20080113975-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, EIF2AK2 KDM4E 2103/4885LMNA 4858/4885ALDH1A1 500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.